HEME OXYGENASE-1 PROSTATIC LEVELS ARE SIGNIFICANTLY LOWER IN PATIENTS AFFECTED BY MODERATE-SEVERE LUTS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA: A PILOT STUDY

被引:0
|
作者
Russo, Giorgio Ivan
Vanella, Luca
Cimino, Sebastiano
Campisi, Daniele
Fragala, Eugenia
Privitera, Salvatore
Favilla, Vincenzo
Castelli, Tommaso
Sorrenti, Valeria
Morgia, Giuseppe
机构
来源
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词
D O I
10.1016/j.juro.2014.02.706
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP19-05
引用
收藏
页码:E190 / E190
页数:1
相关论文
共 50 条
  • [41] Tamsulosin oral controlled absorption system (OCAS) in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH):: Efficacy and tolerability in a placebo and active comparator controlled phase 3a study
    Chapple, CR
    Al-Shukri, SH
    Gattegno, B
    Holmes, S
    Martínez-Sagarra, JM
    Scarpa, RM
    Trip, OBV
    Vik, V
    van der Putten-Slob, I
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) : 33 - 44
  • [42] Tamsulosin oral controlled absorption system (OCAS) in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): Efficacy and tolerability in a phase 2b dose-response study
    Chapple, CR
    Lorenz, J
    Mortensen, R
    Pauthner, H
    Reise, MO
    Schulman, CC
    van der Putten-Slob, I
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) : 25 - 32
  • [43] Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study
    Rosen, Raymond C.
    Roehrborn, Claus G.
    Manyak, Michael J.
    Manuel Palacios-Moreno, Juan
    Wilson, Timothy H.
    Lulic, Zrinka
    Giuliano, Francois
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (09) : 1 - 9
  • [44] An open, comparative, multicentre clinical study of combined oral therapy with sildenafil and doxazosin GITS for treating Chinese patients with erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Jin, Zhe
    Zhang, Zhi-Chao
    Liu, Ji-Hong
    Lu, Jun
    Tang, Yu-Xin
    Sun, Xiang-Zhou
    Song, Wei-Dong
    Gao, Bing
    Guo, Ying-Lu
    Xin, Zhong-Cheng
    ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (04) : 630 - 635
  • [45] Ejaculatory Disorders Caused by Alpha-1 Blockers for Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Comparison of Naftopidil and Tamsulosin in a Randomized Multicenter Study
    Masumori, Naoya
    Tsukamoto, Taiji
    Iwasawa, Akihiko
    Furuya, Ryoji
    Sonoda, Tomoko
    Mori, Mitsuru
    UROLOGIA INTERNATIONALIS, 2009, 83 (01) : 49 - 54
  • [46] Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia - integrated data from 1 499 study participants
    Nickel, John Curtis
    Brock, Gerald B.
    Herschorn, Sender
    Dickson, Ruth
    Henneges, Carsten
    Viktrup, Lars
    BJU INTERNATIONAL, 2015, 115 (05) : 815 - 821
  • [47] Re: Comparison of 7 α1-Adrenoreceptor Antagonists in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: A Short-Term Crossover Study Editorial Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2014, 192 (04): : 1166 - 1167
  • [50] Efficacy and Safety of the Selective alpha(1A)-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea
    Moon, Ki Hak
    Song, Phil Hyun
    Yang, Dae Yul
    Park, Nam Cheol
    Kim, Soo Woong
    Lee, Sung Won
    Kim, Sae Woong
    Moon, Du Geon
    Park, Jong Kwan
    Ahn, Tai Young
    Park, Kwangsung
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (05) : 335 - 340